Article citationsMore>>

Yamamoto, Y. and Gaynor, R.B. (2001) Therapeutic Potential of Inhibition of NF-κb Pathway in the Treatment of Inflammation and Cancer. The Journal of Clinical Investigation, 107, 135-142.

has been cited by the following article:

• TITLE: Treatment of COVID-19 by Controlling the Activity of the Nuclear Factor-Kappa B

  AUTHORS: Mahmoud Saad Mohamed Elkhodary

  KEYWORDS: Cytokine Storm, COVID-19, Nuclear Factor Kappa-B

  JOURNAL NAME: CellBio, Vol.9 No.2, June 5, 2020

  ABSTRACT: Heavy infection of the virus leads to overproduction of cytokines. The overproduction of cytokine (cytokines storms) is responsible for the critical cases and deaths of COVID-19. The nuclear factor kappa-B stimulates the expression of the genes, which is responsible for cytokines storm and RNA transcription. The COVID-19 virus can be controlled by inhibition of nuclear factor kappa-B. Nuclear factor kappa-B is controlled by inhibition of hydrogen peroxide and inhibitor kappa-B kinase enzyme.